Annual Report to the Nation on the Status of Cancer, 1975-2010, Featuring Prevalence of Comorbidity and Impact on Survival among Persons with Lung, Colorectal, Breast or Prostate Cancer

By B. Edwards, A. Noone, A. Mariotto, Edgar P. Simard, F. Boscoe, S. J. Henley, A. Jemal, Hyunsoon Cho, Robert N. Anderson, B. Kohler and 2 more. Cancer, 2013

1,651 citations recorded by the source corpus.

The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate annually to provide updates on cancer incidence and death rates and trends in these outcomes for the United States. This year's report includes the prevalence of comorbidity at the time of first cancer diagnosis among patients with lung, colorectal, breast, or prostate cancer and survival among cancer patients based on comorbidity level.

Subfields: Epidemiology, Oncology

View Paper: https://www.semanticscholar.org/paper/1b160514c6d2e53da5ba25a5a2b3d7d707536ac6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. A. Jemal
2. R. Siegel

In Oncology

1. A. Jemal
2. Jiemin Ma
3. L. Matrisian
4. R. Siegel
5. K. Miller

Citations in the corpus

• Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. (2014, methodology): “Projections of deaths of themost common andmost deadly cancers (a total of 14 cancer types for men and 16 cancer types for women) due to the combined changes of demographics and death rates were calculated using the 2010 number of deaths for men and women as provided by SEER Stat Database (6) and ap”
• Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics (2018, background): “This article has been contributed to by US Government employees, and their work is in the public domain in the United States.”
• CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012 (2015, background): “policy indicates that underreporting for VHA facilities has diminished over time.(30) Delays in reporting and late ascertainment are a reality and a known issue influencing registry completeness and, consequently, rate underestimations occur, especially for the most recent years.”
• Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention (2014, neutral): “8% for women annually from 1992 to 2010 (12).”
• The impact of comorbidity on cancer and its treatment (2016, background): “The impact of comorbidity is greater for early stage cancer compared with advanced cancer for similar reasons.(1,16) There are several reasons why comorbidity impacts survival.”
• Annual Report to the Nation on the Status of Cancer, 1975–2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State (2015, methodology): “More detailed information on our statistical methods is described in previous reports (2).”
• Annual report to the nation on the status of cancer, part 1: National cancer statistics (2022, neutral): “years, artificially inflating the Hispanic AI/AN denominator and thus yielding lower cancer rates for all AI/AN persons.(102,107) In addition, there are issues of misclassification of race and ethnicity in medical records and death certificates, causing underestimation of cancer incidence and death ”